Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model
暂无分享,去创建一个
R. Rossaint | C. Zentai | C. Solomon | P. V. D. van der Meijden | O. Grottke | H. Spronk | Jonas Schnabel
[1] R. Rossaint,et al. Fibrinogen Concentrate Does Not Suppress Endogenous Fibrinogen Synthesis in a 24-hour Porcine Trauma Model , 2014, Anesthesiology.
[2] W. Voelckel,et al. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients , 2014, Critical Care.
[3] H. Redl,et al. Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution , 2014, The journal of trauma and acute care surgery.
[4] D. Fries,et al. Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs , 2014, Transfusion.
[5] P. Wouters,et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. , 2013, European journal of anaesthesiology.
[6] J. Vincent,et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline , 2013, Critical Care.
[7] W. Voelckel,et al. Potential value of pharmacological protocols in trauma , 2013, Current opinion in anaesthesiology.
[8] C. Solomon,et al. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery , 2013, British journal of anaesthesia.
[9] S. Stanworth,et al. The incidence and magnitude of fibrinolytic activation in trauma patients , 2013, Journal of thrombosis and haemostasis : JTH.
[10] H. Wendel,et al. Flow cytometry analysis of porcine platelets: Optimized methods for best results , 2012, Platelets.
[11] A. Sauaia,et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. , 2012, Journal of the American College of Surgeons.
[12] W. Voelckel,et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy , 2012, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.
[13] B. Sørensen,et al. Emerging treatment strategies for trauma‐induced coagulopathy , 2012, The British journal of surgery.
[14] R. Davenport,et al. Management of major trauma haemorrhage: treatment priorities and controversies , 2011, British journal of haematology.
[15] P. Innerhofer,et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. , 2011, British journal of anaesthesia.
[16] R. Rossaint,et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. , 2011, Blood.
[17] S. Bélisle,et al. Prevention and treatment of coagulopathy in patients receiving massive transfusions , 2011, Vox sanguinis.
[18] S. Skrtic,et al. Prophylactic Fibrinogen Infusion in Cardiac Surgery Patients: Effects on Biomarkers of Coagulation, Fibrinolysis, and Platelet Function , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[19] W. Voelckel,et al. Platelet function following trauma , 2011, Thrombosis and Haemostasis.
[20] R. Rossaint,et al. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury , 2010, Critical care.
[21] R. Rossaint,et al. A New Model for Blunt Liver Injuries in the Swine , 2009, European Surgical Research.
[22] S. Skrtic,et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery , 2009, Thrombosis and Haemostasis.
[23] Kenichi A. Tanaka,et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. , 2009, British journal of anaesthesia.
[24] A. Haverich,et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study , 2009, British journal of anaesthesia.
[25] J. Ingerslev,et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo‐controlled clinical trial , 2009, Journal of thrombosis and haemostasis : JTH.
[26] M. Dubick,et al. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. , 2008, The Journal of trauma.
[27] M. Prins,et al. Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory , 2008, Thrombosis and Haemostasis.
[28] Kenichi A. Tanaka,et al. Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P) , 2008, Anesthesia and analgesia.
[29] W. Schobersberger,et al. The Effect of Fibrinogen Substitution on Reversal of Dilutional Coagulopathy: An In Vitro Model , 2006, Anesthesia and analgesia.
[30] W. Kreuz,et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. , 2005, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[31] D. S. Neblock,et al. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. , 1996, Blood.
[32] E. Vahtera,et al. Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates , 1995, Anesthesia and analgesia.
[33] D. Massel,et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.
[34] C. Kolbitsch,et al. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. , 2006, Thrombosis research.